The European MidCap Event takes place in Paris on 21 and 22 September and brings together European investors around promising SMEs. This is an opportunity for Sébastien PELTIER (CEO) and Frédéric PELONG (CFO) to share the remarkable results of the Phase II/III REVERSE-IT clinical study on TOTUM•63 and to communicate Valbiotis’ strategic outlook for the coming months.